Abstract:Imaging flow cytometry (IFC) combines the advantages of flow cytometry (FC) and microscopy to provide detailed morphological insights into platelets. In this study, we evaluated the performance of morphometric features for heparin‐induced thrombocytopenia (HIT) diagnosis. A total of 42 patients with suspected HIT were included: 28 HIT‐positive patients (tested once) and 14 HIT‐negative patients (tested twice). Morphometric features such as size, shape and contrast showed significant changes between resting platelets (negative control, NaCl) and TRAP‐6‐activated platelets (positive control), enabling the detection of platelet activation with IFC. To diagnose HIT, donor platelet‐rich plasma was mixed with patient platelet‐poor plasma in the presence of increasing concentrations of heparin. Subsequently, platelets were labelled with CD62P, an internal marker of platelet activation. Measurements of area, diameter and major axis features reliably identified HIT‐positive patients, with performance levels comparable to those of CD62P expression. This study highlights that IFC is a label‐free, robust and efficient method for detecting platelet activation, offering a promising alternative to conventional functional assays for HIT diagnosis. Summary Heparin‐induced thrombocytopenia (HIT) is an adverse reaction characterized by anti‐PF4‐heparin antibody generation and hypercoagulability. Imaging flow cytometry (IFC) provides a detailed morphological analysis of platelets, which change upon activation. We evaluated IFC‐derived morphometric features to detect platelet activation and developed a functional assay for HIT diagnosis. We analysed blood samples from 42 patients with suspected HIT and extracted platelet size, shape and texture features using IFC. The morphological features were compared with CD62P expression, light transmission aggregometry (LTA) and a serotonin release assay (SRA) in terms of their ability to predict a HIT diagnosis. Five IFC‐derived morphological features (area, circularity, contrast, diameter and major axis) significantly distinguished resting from activated platelets. The major axis feature performed best for HIT diagnosis, with a sensitivity of 89.3% and a specificity of 92.9% versus functional assays (LTA/SRA); this diagnostic performance was similar to that of CD62P expression on the same platelet donors. The area and diameter had similar specificity (92.9%) and a slightly lower sensitivity (85.7%). The morphological features associated with platelet activation might be effective markers for the diagnosis of HIT, matching platelet CD62P expression assay performance. The high‐throughput IFC exploration of platelet activation offers new perspectives in label‐free analysis and time‐saving.

Assessing prognosis by quantifying FcγRIIa on fixed platelets

Platelet FcγRIIa as a Marker of Cardiovascular Risk After Myocardial Infarction

Platelet FcγRIIa Expression in Patients With Stable Coronary Artery Disease

Measurement of procoagulant platelets provides mechanistic insight and diagnostic potential in heparin-induced thrombocytopenia

Formaldehyde-fixation of platelets for flow cytometric measurement of phosphatidylserine exposure is feasible

An ELISA for Quantitative Measurement of Platelet Membrane-Bound Fibrinogen and Its Clinical Value

Flow cytometric immunobead assay for quantitative detection of platelet autoantibodies in immune thrombocytopenia patients

Imaging flow cytometry as a novel approach for the diagnosis of heparin‐induced thrombocytopenia

A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban

Feasibility and comparability of different platelet function tests in acute stroke with or without prior antiplatelet therapy

Droplet Microfluidics with Reagent Micromixing for Investigating Intrinsic Platelet Functionality

Pathogenic heparin-induced thrombocytopenia and thrombosis (HIT) antibodies determined by rapid functional flow cytometry

Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin

Detection of Platelet Sensitivity to Inhibitors of Cox-1, P2y(1), and P2y(12) Using A Whole Blood Microfluidic Flow Assay

A comparative study of platelet factor 4-enhanced platelet activation assays for the diagnosis of heparin-induced thrombocytopenia

Characterization of Platelet-Associated Immunoglobulin by Flow Cytometry.

Comparison of several von Willebrand factor (VWF) activity assays for monitoring patients undergoing treatment with VWF/FVIII concentrates: improved performance with a new modified automated method.

An update on quality control for the PFA-100/PFA-200

Improved method for fluorescence cytometric immunohematology testing

Development of a novel flow cytometric immunobead array to quantify VWF: Ag and VWF: GPIbR and its application in acute myocardial infarction.

Detection of Autoantibodies Against Platelet Glycoproteins in Patients with Immune Thrombocytopenic Purpura by Flow Cytometric Immunobead Array.